LBI-HTA - Publications - Search - Selective Cell Apheresis in Inflammatory Bowel Disease

Adlbrecht, C. and Breyer, E. and Gartlehner, G. and Guba, B. (2008): Selective Cell Apheresis in Inflammatory Bowel Disease. Decision Support Document 11.

This is the latest version of this item.

PDF (selective cell apheresis - decision support document #11) - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader

Selective Cell Apheresis (SCA)

Inflammatory bowel disease (Crohn's disease and colitis ulcerosa) are usually treated with antiinflammatory drugs or by surgical interventions. SCA is a subtype of apheresis where leukocytes are removed to reduce the inflammation. In a systematic search for available evidence for efficacy and safety of this intervention 4 randomised controlled studies as well as 8 uncontrolled interventional studies complied to the inclusion criteria. Although all of the studies present weakness of methodological quality, a nett benefit for the treatment of Colitis ulcerosa can be assumed. Therefore a restricted recommendation for the intervention of SCA can be made.

Item Type:Decision Support Document
Keywords:selective cell adsorption leukocyte apheresis apheresis Morbus Crohn Colitis ulcerosa
Subjects:WI Digestive system > WI 400-560 Intestines
Series Name:Decision Support Document
Deposited on:09 Aug 2008 12:57
Last Modified:07 Nov 2008 19:17

Available Versions of this Item

Repository Staff Only: item control page